With 809 citations, a clinical trial by Barcelona’s August Pi i Sunyer Biomedical Research Institute (IDIBAPS) is the world’s most often cited study in the field of cancer. The study, published in 2008 in the New England Journal of Medicine, demonstrates the positive effect of the drug Sorafenib on the survival of patients with advanced liver cancer

STAFF | APRIL 13TH, 2011

Researchers at Vall d'Hebron Hospital have identified a group of 20 genes linked to the development of uterine cancer and have created a new test for its diagnosis that does not require a biopsy and that can be done in the doctor’s office.

STAFF | MARCH 29TH, 2011

Bottled water does not prevent exposure to contaminants in tap water, according to a study led by Catalonia’s Centre for Research in Environmental Epidemiology. This study has established that the entire population is exposed to water pollutants either through drinking tap water or from showers, baths and swimming pools

STAFF | March 16th, 2011

A study led by Manel Esteller of Barcelona’s Institute of Biomedical Research of Bellvitge has identified a drug that inhibits cancer growth by activating the genome’s so-called “dark matter” (or non-coding DNA) and microRNA molecules. The study is published in Proceedings of the National Academy of Sciences

STAFF | MARCH 2ND, 2011